• FREE

    Chronic inflammatory demyelinating polyneuropathy (CIDP): therapeutic updates, best practices, and emerging therapies

    Chronic inflammatory demyelinating polyneuropathy (CIDP) is a chronic, acquired, autoimmune disorder affecting the peripheral nervous system. Symptoms of CIDP include progressive limb weakness, usually with a predilection for proximal muscles, and sensory loss and are monophasic and progress for 8 weeks or more.

    After viewing Chronic inflammatory demyelinating polyneuropathy (CIDP), you will be able to:
    • Describe the pathophysiology of CIDP such that it might inform treatment mechanisms
    • Identify the currently available and emerging pharmacotherapeutic treatments for management of CIDP and apply them to patient cases using evidence-based medicine
    • Modify an existing treatment plan for a specific patient with CIDP to optimize safety and efficacy following non-response to therapy
    • Describe non-pharmacological options to manage CIDP

    Target Audience:
    Healthcare professionals specializing in: neurology, internal medicine; nurse practitioners, physician assistants, nurses, and pharmacists who specialize in neurology; and those who otherwise commonly care for or clinically encounter patients with CIDP.

    • Cost: Free
    • Credit hours: 0.75
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: January 19, 2018
    • Expiration of CME credit: January 19, 2020
  • FREE

    A 360° Approach to Translating MS Data into Optimal Practice

    A 360° Approach to Translating MS Data into Optimal Practice focuses on practical topics, review clinical trial data with clarity and thoroughness, and incorporates cases to engage you on how this information can be used in clinical practice, for all disciplines involved in the care of patients with MS.

    Upon completion of A 360° Approach to Translating MS Data into Optimal Practice, you should be better able to:
    • Analyze data from clinical trials of disease modifying therapies to inform personalized treatment and monitoring of outcomes for patients with MS
    • Access reliable and evidence-based resources in order to stay current with advances in the management of MS
    • Integrate new and emerging information on the pathophysiology of MS, including modifiable risk factors, in the development of individualized treatment plans

    Target Audience:
    This educational initiative is intended to meet the needs of neurologists, nurses, nurse practitioners, physician assistants, rehabilitation professionals, case managers, mental health professionals, social workers and others involved in the management of patients with MS.

    • Cost: Free
    • Credit hours: 3
    • CME credits awarded by: Consortium of Multiple Sclerosis Centers
    • Format: On-Demand Online, Online Audio
    • Material last updated: July 31, 2017
    • Expiration of CME credit: July 30, 2018
  • FREE

    Treatment Updates on Chronic Inflammatory Demyelinating Polyneuropathy

    Treatment Updates on Chronic Inflammatory Demyelinating Polyneuropathy emphasizes the use of IVIg in the treatment of Chronic Inflammatory Demyelinating Polyneuropathy.

    The presentation consists of a single lecture, Treatment Updates on Chronic Inflammatory Demyelinating Polyneuropathy, with discussion by Roy L. Freeman, MD, Richard J. Barohn, MD and Kenneth C. Gorson, MD.

    After viewing Treatment Updates on Chronic Inflammatory Demyelinating Polyneuropathy, you will be better able to :
    • Conduct a thorough and timely evaluation and differential diagnosis of patients with chronic inflammatory demyelinating polyneuropathy.
    • Devise appropriate treatment regimen for the effective management of chronic inflammatory polyneuropathy based on guidelines and clinical evidence.

    Target Audiences:
    This program is intended for US-based neurologists, immunologists, physician assistants, nurse practitioners, and nurses who manage, or have an interest in managing patients with immune-mediated neuropathies.

    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: Postgraduate Institute for Medicine
    • Format: On-Demand Online, Online Video
    • Material last updated: July 27, 2017
    • Expiration of CME credit: July 27, 2018
  • FREE

    Neuropsychiatric Sequelae Virtual Curriculum Series: Agitation, Depression, and Pseudobulbar Affect

    Neuropsychiatric Sequelae Virtual Curriculum Series: Agitation, Depression, and Pseudobulbar Affect consists of two sections: Mechanisms and Management of Agitation in Alzheimer’s Disease and Challenges in Managing Treatment-Resistant Depression.

    After viewing Neuropsychiatric Sequelae Virtual Curriculum Series, you will be better able to:
    • Identify different and various forms of agitation among patients with Alzheimer’s disease (AD).
    • Review proposed mechanisms underlying agitation in AD and how pharmacologic agents may affect them
    • Evaluate body of evidence of current and emerging pharmacologic agents for the management of agitation/aggression in patients with AD

    Target Audiences:
    This program is intended for US-based neurologists, psychiatrists, geriatricians, primary care clinicians and health care providers involved in the care of patients with neuropsychiatric sequelae who may be suffering from agitation as a result of Alzheimer’s disease (AD).

    • Cost: Free
    • Credit hours: 2
    • CME credits awarded by: Albert Einstein College of Medicine
    • Format: On-Demand Online, Online Video
    • Material last updated: April 4, 2017
    • Expiration of CME credit: June 23, 2018
  • FREE

    Treatment strategies in Hunter Syndrome

    Hunter syndrome is an X-linked recessive genetic disease characterized by a deficiency of lysosomal enzymes responsible for the hydrolysis of glycosaminoglycans (GAGs), with males more likely to develop disease and females more likely to be carriers.

    After reviewing Treatment strategies in Hunter Syndrome, you will be able to:
    • Describe the importance of earlier treatment and diagnosis of Hunter syndrome in patients
    • Determine the likelihood of Hunter syndrome using with established diagnosis methods, given a patient case
    • Describe options available to treat Hunter syndrome and design a medical plan to treat a patient with Hunter syndrome
    • Describe present barriers to care in the treatment of patients with Hunter syndrome

    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: June 29, 2017
    • Expiration of CME credit: June 29, 2019
  • FREE

    Updates in Migraine Headaches: Best practices and Emerging Therapies in Treatment and Prevention

    After viewing Updates in Migraine Headaches, you will be able to:
    • Describe the prevalence of migraine symptoms and the impact that these symptoms have on efficacy of anti-migraine therapy and functional status
    • Describe the sometimes variable manifestations (e.g., incidence and clinical presentation) of migraine headaches, depending on age and sex
    • Recall emerging therapies for the treatment and prevention of chronic migraine headache and anticipate their place in therapy
    • Support team-based learning and communication between all clinicians involved with the care of patients suffering with migraines
    • Given a series of patient cases, diagnosis and treat migraine headaches by employing current treatment guidelines, using evidence-based therapy algorithms, and providing individualized approaches to care

    Target Audiences:
    Healthcare professionals who are: primary care physicians, neurologists, headache specialists, nurse practitioners, physician assistants, nurses, OB-GYN specialists, pharmacists, and those who otherwise commonly care for or clinically encounter patients who may experience migraine headache.

    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: July 20, 2016
    • Expiration of CME credit: July 20, 2018
  • FREE

    ScientiaCME Treatment strategies in Gaucher disease

    At the conclusion of By the end of Treatment strategies in Gaucher disease, you will be able to:
    • Describe the importance of appropriate GD (Gaucher Disease) diagnosis and treatment (use • for bullets)
    • Determine the likelihood of GD using with established diagnosis methods, given a patient case
    • Describe present therapies for the treatment of GD and the literature supporting their use
    • Design a medical plan to treat a patient with GD, taking into account presently available therapies

    Target Audience:
    Physicians focusing on Cardiology, genetic disorders, hematology, oncology, orthopedics, gastroenterology, neurology and pediatrics.

    • Cost: Free
    • Credit hours: 1.5
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: February 12, 2017
    • Expiration of CME credit: February 12, 2019
  • FREE

    Updates in Alzheimer Disease (AD) and Its Complications: Pharmacotherapy and Barriers to Optimal Care

    This free online CME course provides key insights around Alzheimer’s Disease (AD) and will lead to better understanding and treatment of the condition.

    Topics covered in this course include:

    • AD Treatment
    • AD Patient Cases
    • AD Clinical Pearls
    • ADPathophysiological process
    • Epidemiology

    After completing this course, you will better be able to:

    • Describe validated diagnostic and screening method(s) for AD and apply them to a patient case
    • Discuss the neuropathophysiology of AD and how it relates to presently available AD treatments’ mechanisms
    • List present and emerging pharmacotherapeutic therapies for the treatment of AD and its complications and apply them to patient cases, taking into account comorbid disease states and drug therapies
    • Describe the impact of medication adherence on patient outcomes and formulate strategies to improve adherence in patients with AD

    Target audience: Healthcare professionals specializing in: neurology, gerontology, internal medicine, palliative care, or those who otherwise commonly care for patients with AD or who frequently encounter them or their caregivers in practice.

    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: July 07, 2018
    • Expiration of CME credit: July 07, 2020
  • FREE

    Parkinson’s Disease: Optimizing Pharmacotherapeutic Management Strategies

    This free online CME activity provides insights into Parkinson’s disease (PD) and will help improve treatment amongst patients suffering from the disease.

    Topics covered in this course include:

    • PD Epidemiology
    • PD Clinical features, presentation (motor symptoms), pathophysiology, risk factors (e.g., Gaucher’s disease, differential diagnosis and disease progression
    • PD Patient Cases
    • Treatment of PD

    After completing this course, you will better be able to:

    • Describe the epidemiology of PD and outline current and evolving diagnostic criteria
    • Describe the challenges associated with the diagnosis of PD
    • Identify the treatment modalities currently available for management of PD and its complications and apply them to patient cases using evidence-based medicine
    • List emerging pharmacologic therapies for the treatment of PD
    • Describe the impact of medication adherence on patient outcomes and formulate strategies to improve adherence in patients with PD

    Target Audience: Neurologists and primary care physicians; physician assistants, nurse practitioners, nurses, and pharmacists who practice in neurology; and any other healthcare professionals with an interest in or who clinically encounter patients with PD.

    • Cost: Free
    • Credit hours: 1,25
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: March 27, 2018
    • Expiration of CME credit: March 27, 2020